Mariska L. Reedijk

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption

Sabine Allard, Brenda De Keersmaecker, Anna L. de Goede et al. · Clinical Immunology · 2011 · 119 citations

Life Sciences, Immunology, Infectious Diseases +17

Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots

Roland J. W. Meesters, Jeroen J. A. van Kampen, Mariska L. Reedijk et al. · Analytical and Bioanalytical Chemistry · 2010 · 64 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

A mass spectrometry based imaging method developed for the intracellular detection of HIV protease inhibitors

Lennard J. M. Dekker, Jeroen J. A. van Kampen, Mariska L. Reedijk et al. · Rapid Communications in Mass Spectrometry · 2009 · 48 citations

Pharmacy, Cell Biology, Pharmacology +14

Ultra-Fast Analysis of Plasma and Intracellular Levels of HIV Protease Inhibitors in Children: A Clinical Application of MALDI Mass Spectrometry

Jeroen J. A. van Kampen, Mariska L. Reedijk, Peter C. Burgers et al. · PLoS ONE · 2010 · 28 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Fluorescent Antigen–Transfected Target Cell Cytotoxic T Lymphocyte Assay for Ex Vivo Detection of Antigen‐Specific Cell‐Mediated Cytotoxicity

Carel A. van Baalen, David Kwa, Esther J. Verschuren et al. · The Journal of Infectious Diseases · 2005 · 28 citations · Full text

Life Sciences, Cell Biology, Immunology +17